347 related articles for article (PubMed ID: 188956)
1. Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia.
Shattil SJ; Bennett JS; Colman RW; Cooper RA
J Lab Clin Med; 1977 Feb; 89(2):341-53. PubMed ID: 188956
[TBL] [Abstract][Full Text] [Related]
2. Platelet function in hyperbetalipoproteinemia.
Colman RW
Thromb Haemost; 1978 Apr; 39(2):284-93. PubMed ID: 580982
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol:phospholipid ratio is elevated in platelet plasma membrane in patients with hypertension.
Benjamin N; Robinson BF; Graham JG; Wilson RB
J Hum Hypertens; 1990 Jun; 4(3):273-6. PubMed ID: 2362260
[TBL] [Abstract][Full Text] [Related]
4. [The effect of oxidized low density lipoproteins on ADP-induced platelet aggregation in plasma].
Vlasova II; Vakhrusheva TV; Azizova OA; Lopukhin IuM
Vopr Med Khim; 1998; 44(1):43-54. PubMed ID: 9575612
[TBL] [Abstract][Full Text] [Related]
5. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL
Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702
[TBL] [Abstract][Full Text] [Related]
6. Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells.
Cooper RA
J Supramol Struct; 1978; 8(4):413-30. PubMed ID: 723275
[TBL] [Abstract][Full Text] [Related]
7. Platelet hypersensitivity induced by cholesterol incorporation.
Shattil SJ; Anaya-Galindo R; Bennett J; Colman RW; Cooper RA
J Clin Invest; 1975 Mar; 55(3):636-43. PubMed ID: 1117069
[TBL] [Abstract][Full Text] [Related]
8. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
Ravindran R; Krishnan LK
Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
[TBL] [Abstract][Full Text] [Related]
9. Platelet alpha 2-adrenergic receptors in hypercholesterolemia: relationship between binding studies and epinephrine-induced platelet aggregation.
Baldassarre D; Mores N; Colli S; Pazzucconi F; Sirtori CR; Tremoli E
Clin Pharmacol Ther; 1997 Jun; 61(6):684-91. PubMed ID: 9209252
[TBL] [Abstract][Full Text] [Related]
10. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.
Bilheimer DW; Stone NJ; Grundy SM
J Clin Invest; 1979 Aug; 64(2):524-33. PubMed ID: 222811
[TBL] [Abstract][Full Text] [Related]
11. Halofenate: a potent inhibitor of normal and hypersensitive platelets.
Colman RW; Bennett JS; Sheridan JF; Cooper RA; Shattil SJ
J Lab Clin Med; 1976 Aug; 88(2):282-91. PubMed ID: 956686
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
Schrör K; Löbel P; Steinhagen-Thiessen E
Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
[TBL] [Abstract][Full Text] [Related]
13. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
14. Plasma lipoprotein pattern and decreased platelet function in type V hyperlipoproteinemia.
Aviram M; Brook JG
Isr J Med Sci; 1985 Nov; 21(11):898-904. PubMed ID: 4077486
[TBL] [Abstract][Full Text] [Related]
15. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
[TBL] [Abstract][Full Text] [Related]
16. Membrane microviscosity and human platelet function.
Shattil SJ; Cooper RA
Biochemistry; 1976 Nov; 15(22):4832-7. PubMed ID: 990246
[TBL] [Abstract][Full Text] [Related]
17. Interactions between lipoproteins and platelet membranes in obesity.
Raffaelli F; Nanetti L; D'Angelo M; Montecchiani G; Alidori A; Montesi L; Faloia E; Vignini A; Mazzanti L
Obesity (Silver Spring); 2009 Jul; 17(7):1375-80. PubMed ID: 19197263
[TBL] [Abstract][Full Text] [Related]
18. Plasma HDL-cholesterol has an effect on nitric oxide production and arachidonic acid metabolism in the platelet membranes of coronary heart disease patients without LDL-hypercholesterolemia.
Tretjakovs P; Kalnins U; Dabina I; Dinne I; Erglis A; Kumsars I; Jurka A
Med Sci Monit; 2000; 6(3):507-11. PubMed ID: 11208362
[TBL] [Abstract][Full Text] [Related]
19. Influence of cholesterol-lowering on plasma membrane lipids and function.
Lijnen P; Echevaría-Vázquez D; Petrov V
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
[TBL] [Abstract][Full Text] [Related]
20. [Plasma lipoproteins and aortic collagen fractions in rabbits with different degrees of atherosclerosis].
Gerasimova EN; Torkhovskaia TI; Perova NV; Bazanova EA
Vopr Med Khim; 1979; 25(4):471-80. PubMed ID: 224599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
